• 1. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 2. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 3. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 4. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 5. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832

Professional Introduction to Compound with CAS No. 1224932-55-1 and Product Name: 4-(4-((Dimethylamino)methyl)piperidin-1-yl)aniline

The compound in question, identified by the CAS No. 1224932-55-1, is a sophisticated organic molecule that has garnered significant attention in the field of pharmaceutical chemistry. This compound, more specifically referred to by the product name 4-(4-((Dimethylamino)methyl)piperidin-1-yl)aniline, represents a class of molecules that exhibit promising biological activities. Its structural framework, characterized by a piperidine ring substituted with a dimethylamino methyl group and connected to an aniline moiety, positions it as a candidate for further exploration in drug discovery and development.

In recent years, the pharmaceutical industry has witnessed a surge in interest towards molecules that incorporate piperidine and aniline motifs. These structural features are not only biologically relevant but also offer tunable pharmacophores for designing novel therapeutic agents. The 4-(4-((Dimethylamino)methyl)piperidin-1-yl)aniline molecule, with its unique substitution pattern, is anticipated to interact with biological targets in ways that could lead to the development of new treatments for various diseases.

One of the most compelling aspects of this compound is its potential as a scaffold for medicinal chemistry. The presence of the dimethylamino group enhances the lipophilicity of the molecule, which is often a critical factor in drug bioavailability. Additionally, the piperidine ring is known to be a privileged structure in many approved drugs, suggesting that derivatives of this compound may possess favorable pharmacokinetic properties. The aniline moiety further contributes to its potential as a bioactive entity by providing a site for hydrogen bonding interactions with biological targets.

Recent studies have highlighted the importance of understanding the three-dimensional structure of molecules like 4-(4-((Dimethylamino)methyl)piperidin-1-yl)aniline to predict their biological activity accurately. Advanced computational techniques, such as molecular dynamics simulations and quantum mechanical calculations, have been employed to model the interactions of this compound with potential biological targets. These studies have provided valuable insights into how the substitution pattern influences the molecule's binding affinity and selectivity.

The synthesis of 4-(4-((Dimethylamino)methyl)piperidin-1-yl)aniline represents a significant achievement in synthetic organic chemistry. The multi-step synthesis involves strategic functional group transformations and precise regioselective reactions. The use of advanced catalytic systems has enabled chemists to construct the complex framework of this molecule with high efficiency and yield. This synthetic approach not only underscores the ingenuity of modern chemical methodology but also opens up avenues for producing analogs with tailored properties.

From a medicinal chemistry perspective, the exploration of 4-(4-((Dimethylamino)methyl)piperidin-1-yl)aniline has led to several promising derivatives that exhibit enhanced biological activity. For instance, modifications at the dimethylamino group have been shown to modulate receptor binding affinity, while alterations at the aniline moiety can influence metabolic stability. These findings underscore the importance of structure-activity relationships (SAR) in optimizing drug candidates.

The potential therapeutic applications of this compound are vast. Preliminary in vitro studies have suggested that derivatives of 4-(4-((Dimethylamino)methyl)piperidin-1-yl)aniline may exhibit efficacy against various targets, including kinases and G protein-coupled receptors (GPCRs). These targets are implicated in numerous diseases, making this compound a versatile tool for drug discovery. Further preclinical studies are warranted to validate these findings and explore its potential as a lead compound for therapeutic development.

The role of computational chemistry in understanding the behavior of complex molecules like 4-(4-((Dimethylamino)methyl)piperidin-1-yl)aniline cannot be overstated. By leveraging machine learning algorithms and artificial intelligence (AI), researchers can predict biological activity with remarkable accuracy. These computational tools have accelerated the drug discovery process by enabling high-throughput virtual screening and de novo design of novel molecules.

In conclusion, CAS No. 1224932-55-1 represents a structurally intriguing molecule with significant potential in pharmaceutical research. The product name 4-(4-((Dimethylamino)methyl)piperidin-1-yl)aniline highlights its unique substitution pattern, which positions it as a promising scaffold for drug discovery. With advancements in synthetic chemistry, computational methods, and biological assays, this compound is poised to contribute to the development of new therapeutic agents that address unmet medical needs.

• 2359-60-6(4-(piperidin-1-yl)aniline)
• 4096-20-2(1-Phenyl-piperidine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)